Researchers learned that an experimental drug that blocks CD28, a molecular pathway expressed on immune system T cells, helped prevent organ rejection in monkeys that underwent a kidney or heart transplant when given in combination with immunosuppressant treatments. Study authors hope the results will lead to the development of better organ-transplant medicines.

Related Summaries